Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
'Stealth' nanoparticles evade neural immune cells but also evade major brain cell populations: Implications for PEG-based neurotherapeutics.
Association of IL-23 and its receptor gene single nucleotide polymorphisms with Multiple Sclerosis in Chinese Southern Population.
Applying the RE-AIM Framework to Inform the Development of a Multiple Sclerosis Falls-Prevention Intervention.
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
In vivo imaging of human neuroinflammation.
Erratum to: Reassessing the risk of natalizumab-associated PML.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: Support for electrically-active myelin in mammalian saltatory conduction.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
MicroRNA: Key regulators of oligodendrocyte development and pathobiology.
Three decades of drift: the misdiagnosis of predominantly neuropsychiatric multiple sclerosis.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Charles bonnet syndrome after herpes simplex encephalitis.
Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.
Effects of Omega-3 Fatty Acid Supplementation on Cognitive Functions and Neural Substrates: A Voxel-Based Morphometry Study in Aged Mice.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Activation of endogenous neural stem cells for multiple sclerosis therapy.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
690
691
692
693
694
695
696
697
698
…
next ›
last »